Worldwide pandemics of obesity and diabetes prompt an urgent need for new approaches to their prevention and cure. Here the authors present a CRISPR-based strategy that enhances the therapeutic potential of human adipocytes when implanted in obese mice.
- Emmanouela Tsagkaraki
- Sarah M. Nicoloro
- Michael P. Czech